Contextualising psychological distress among regular ecstasy users: The importance of sociodemographic factors and patterns of drug use

Drug and Alcohol Review

Volumn 29, Issue 3, 2010, Pages 243-249

  George, Jessica ^a   Kinner, Stuart A ^b   Bruno, Raimondo ^c   Degenhardt, Louisa ^d   Dunn, Matthew ^d  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety; Depression; Ecstasy; Polydrug use; Psychological distress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; DEMOGRAPHY; DRUG ABUSE; FEMALE; HUMAN; MALE; MENTAL STRESS; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; DEMOGRAPHY; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 77957335252     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00159.x     Document Type: Article

References (39)

1. Parrott AC, Sisk E, Turner JJD. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend 2000;60:105-10.
2. Parrott AC, Milani RM, Parmar R, Turner JJ. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology 2001;159:77-82.
3. Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A. Mental disorders in current and former heavy ecstasy (MDMA) users. Addiction 2005;100: 1310-19.
4. Gamma A, Frei E, Lehmann D, Pascual RD, Hell D, Vollenweider FX. Mood state and brain electric activity in Ecstasy users. Neuroreport 2000;11:157-62.
5. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C. Chronic MDMA (ecstasy) use, cognition, and mood. Psychopharmacology 2004;173:434-9.
6. Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E. Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol 2001;16:627-33.
7. de Win MML, Reneman L, Reitsma JB, de Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transported density in ecstasy users-the influence of longterm abstention, dose, and gender. Psychopharmacology 2004;173:376-82.
8. Gerra G, Zaimovic A, Giucastro G, et al. Serotonergic function after 3,4-methylenedioxymethamphetamine ('Ecstasy') in humans. Int Clin Psychopharmacol 1998;13:1-9.
9. Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M. Long-lasting effects of 3,4-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biol Psychiatry 2000;47:127-36.
10. Sumnall HR, Wagstaff GF, Cole JC. Self-reported psychopathology in polydrug users. J Psychopharmacol 2004;18: 63-9.
11. Sumnall HR, Cole JC. Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: a meta-analysis. J Psychopharmacol 2005;19:84-92.
12. Gouzoulis-Mayfrank E, Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 2006;20:188-93.
13. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology 2004;173:398-404.
14. Medina KL, Shear PK. Anxiety, depression, and behavioural symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend 2007;87:303-11.
15. Morgan MJ, McFie L, Fleetwood LH, Robinson JA. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 2002;159:294-303.
16. Roiser JP, Sahakian BJ. Relationship between ecstasy use and depression: a study controlling for poly-drug use. Psychopharmacology 2004;173:411-17.
17. Verdejo-Garcia AJ, Lopez-Torrecillas F, de Arcos FA, Perez-Garcia M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav 2005;30:89-101.
18. Andrews G, Hall W, Teeson M, Henderson S. The mental health of Australians. Canberra: Commonwealth Department of Health and Agein, 1999.
19. Comino EJ, Harris E, Chey T, et al. Relationship between mental health disorders and unemployment status in Australian adults. Aust N Z J Psychiatry 2003;37:230-5.
20. Taylor R, Page A, Morrell S, Carter G, Harrison J. Socio-economic differentials in mental disorders and suicide attempts in Australia. Br J Psychiatry 2004;185:486-93.
21. Topp L, Breen C, Kaye S, Darke S. Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'. Drug Alcohol Depend 2004;73:189-97.
22. Dunn M, Degenhardt L, Campbell G, et al. Australian trends in ecstasy and related drug markets 2006: findings from the Ecstasy and related Drugs Reporting System (EDRS). National Drug and Alcohol Research Centre Monograph No. 61. Sydney: National Drug and Alcohol Research Centre, University of New SouthWales, 2007.
23. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2002;60:184-9.
24. Australian Bureau of Statistics. Information paper: use of the Kessler Psychological Distress Scale in ABS Health Surveys, Australia, 2001. Canberra: Australian Bureau of Statistics, 2001.
25. Furukawa TA, Kessler RC, Slade T, Andrews G. The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health andWell-being. Psychol Med 2003;33:357-62.
26. Hides L, Lubman DI, Devlin H, et al. Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust N Z J Psychiatry 2007;41:166-8.
27. Biernacki P, Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol Methods Res 1981;10:141-63.
28. Topp L, Barker B, Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug Alcohol Depend 2004;73:33-40.
29. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Pub Health 2001;25:494-7.
30. Australian Bureau of Statistics. National Survey of Mental Health andWellbeing: summary of results 2007. Canberra: Commonwealth of Australia, 2008.
31. Najman JM, Aird RL, Bor W, O'Callaghan MJ, Williams GM, Shuttlewood GJ. The generational transmission of socio-economic inequalities in child cognitive development and emotional health. Soc Sci Med 2004;58:1147-58.
32. Miech R, Power C, Eaton WW. Disparities in psychological distress across education and sex: a longitudinal analysis of their persistence within a cohort over 19 years. Ann Epidemiol 2007;17:289-95.
33. Guillot C. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? J Psychoactive Drugs 2007;39:31-9.
34. Moore T, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319-28.
35. Loxton NJ, Wan VLN, Ho AMC, et al. Impulsivity in Hong Kong-Chinese club-drug users. Drug Alcohol Depend 2008;95:81-9.
36. Butler GKL, Montgomery AMJ. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 2004;76:55-62.
37. Quinn C, Breen C, White B. Illicit tablet market in Victoria. Party Drug Trends Bulletin (June 2004). Sydney: National Drug and Alcohol Centre, University of New SouthWales, 2004.
38. Alati R, Kinner SA, Hayatbakhsh MR, Mamun AA, Najman JM, Williams GM. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance? Drug Alcohol Depend 2008;92:108-15.
39. de Win MML, Schilt T, Reneman L, et al. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol 2006;20: 226-35.